These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


359 related items for PubMed ID: 21949095

  • 1. Mdm2 promotes systemic lupus erythematosus and lupus nephritis.
    Allam R, Sayyed SG, Kulkarni OP, Lichtnekert J, Anders HJ.
    J Am Soc Nephrol; 2011 Nov; 22(11):2016-27. PubMed ID: 21949095
    [Abstract] [Full Text] [Related]

  • 2. IL-12 deficiency in MRL-Fas(lpr) mice delays nephritis and intrarenal IFN-gamma expression, and diminishes systemic pathology.
    Kikawada E, Lenda DM, Kelley VR.
    J Immunol; 2003 Apr 01; 170(7):3915-25. PubMed ID: 12646661
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Interleukin 6 (IL-6) deficiency delays lupus nephritis in MRL-Faslpr mice: the IL-6 pathway as a new therapeutic target in treatment of autoimmune kidney disease in systemic lupus erythematosus.
    Cash H, Relle M, Menke J, Brochhausen C, Jones SA, Topley N, Galle PR, Schwarting A.
    J Rheumatol; 2010 Jan 01; 37(1):60-70. PubMed ID: 19955044
    [Abstract] [Full Text] [Related]

  • 5. Deletion of receptor for advanced glycation end products exacerbates lymphoproliferative syndrome and lupus nephritis in B6-MRL Fas lpr/j mice.
    Goury A, Meghraoui-Kheddar A, Belmokhtar K, Vuiblet V, Ortillon J, Jaisson S, Devy J, Le Naour R, Tabary T, Cohen JH, Schmidt AM, Rieu P, Touré F.
    J Immunol; 2015 Apr 15; 194(8):3612-22. PubMed ID: 25762779
    [Abstract] [Full Text] [Related]

  • 6. IL-34-Dependent Intrarenal and Systemic Mechanisms Promote Lupus Nephritis in MRL-Faslpr Mice.
    Wada Y, Gonzalez-Sanchez HM, Weinmann-Menke J, Iwata Y, Ajay AK, Meineck M, Kelley VR.
    J Am Soc Nephrol; 2019 Feb 15; 30(2):244-259. PubMed ID: 30622154
    [Abstract] [Full Text] [Related]

  • 7. Viral double-stranded RNA aggravates lupus nephritis through Toll-like receptor 3 on glomerular mesangial cells and antigen-presenting cells.
    Patole PS, Gröne HJ, Segerer S, Ciubar R, Belemezova E, Henger A, Kretzler M, Schlöndorff D, Anders HJ.
    J Am Soc Nephrol; 2005 May 15; 16(5):1326-38. PubMed ID: 15772251
    [Abstract] [Full Text] [Related]

  • 8. Deletion of Mir223 Exacerbates Lupus Nephritis by Targeting S1pr1 in Faslpr/lpr Mice.
    Hiramatsu-Asano S, Sunahori-Watanabe K, Zeggar S, Katsuyama E, Mukai T, Morita Y, Wada J.
    Front Immunol; 2020 May 15; 11():616141. PubMed ID: 33574820
    [Abstract] [Full Text] [Related]

  • 9. EGR2 is elevated and positively regulates inflammatory IFNγ production in lupus CD4+ T cells.
    Dai R, Heid B, Xu X, Xie H, Reilly CM, Ahmed SA.
    BMC Immunol; 2020 Jul 09; 21(1):41. PubMed ID: 32646370
    [Abstract] [Full Text] [Related]

  • 10. The centromeric region of chromosome 7 from MRL mice (Lmb3) is an epistatic modifier of Fas for autoimmune disease expression.
    Kong PL, Morel L, Croker BP, Craft J.
    J Immunol; 2004 Mar 01; 172(5):2785-94. PubMed ID: 14978078
    [Abstract] [Full Text] [Related]

  • 11. BTK inhibition ameliorates kidney disease in spontaneous lupus nephritis.
    Chalmers SA, Glynn E, Garcia SJ, Panzenbeck M, Pelletier J, Dimock J, Seccareccia E, Bosanac T, Khalil S, Harcken C, Webb D, Nabozny G, Fine JS, Souza D, Klein E, Herlitz L, Ramanujam M, Putterman C.
    Clin Immunol; 2018 Dec 01; 197():205-218. PubMed ID: 30339790
    [Abstract] [Full Text] [Related]

  • 12. Deficient leptin signaling ameliorates systemic lupus erythematosus lesions in MRL/Mp-Fas lpr mice.
    Fujita Y, Fujii T, Mimori T, Sato T, Nakamura T, Iwao H, Nakajima A, Miki M, Sakai T, Kawanami T, Tanaka M, Masaki Y, Fukushima T, Okazaki T, Umehara H.
    J Immunol; 2014 Feb 01; 192(3):979-84. PubMed ID: 24391210
    [Abstract] [Full Text] [Related]

  • 13. IL-10 regulates murine lupus.
    Yin Z, Bahtiyar G, Zhang N, Liu L, Zhu P, Robert ME, McNiff J, Madaio MP, Craft J.
    J Immunol; 2002 Aug 15; 169(4):2148-55. PubMed ID: 12165544
    [Abstract] [Full Text] [Related]

  • 14. Negative role of colony-stimulating factor-1 in macrophage, T cell, and B cell mediated autoimmune disease in MRL-Fas(lpr) mice.
    Lenda DM, Stanley ER, Kelley VR.
    J Immunol; 2004 Oct 01; 173(7):4744-54. PubMed ID: 15383612
    [Abstract] [Full Text] [Related]

  • 15. Abnormal thymic maturation and lymphoproliferation in MRL-Fas lpr/lpr mice can be partially reversed by synthetic oligonucleotides: implications for systemic lupus erythematosus and autoimmune lymphoproliferative syndrome.
    Ashman RF, Singh N, Lenert PS.
    Lupus; 2017 Jun 01; 26(7):734-745. PubMed ID: 27837196
    [Abstract] [Full Text] [Related]

  • 16. Administration of activated lymphocyte-derived DNA accelerates and aggravates lupus nephritis in B6/lpr mice: a new approach to modify a lupus murine model.
    Zhu Y, Yue Y, Xiong S.
    Clin Exp Immunol; 2018 Sep 01; 193(3):302-312. PubMed ID: 29704464
    [Abstract] [Full Text] [Related]

  • 17. B cells are required for lupus nephritis in the polygenic, Fas-intact MRL model of systemic autoimmunity.
    Chan OT, Madaio MP, Shlomchik MJ.
    J Immunol; 1999 Oct 01; 163(7):3592-6. PubMed ID: 10490951
    [Abstract] [Full Text] [Related]

  • 18. Recombinant chaperonin 10 suppresses cutaneous lupus and lupus nephritis in MRL-(Fas)lpr mice.
    Kulkarni OP, Ryu M, Kantner C, Sárdy M, Naylor D, Lambert D, Brown R, Anders HJ.
    Nephrol Dial Transplant; 2012 Apr 01; 27(4):1358-67. PubMed ID: 21987536
    [Abstract] [Full Text] [Related]

  • 19. Chemokine receptor Ccr2 deficiency reduces renal disease and prolongs survival in MRL/lpr lupus-prone mice.
    Pérez de Lema G, Maier H, Franz TJ, Escribese M, Chilla S, Segerer S, Camarasa N, Schmid H, Banas B, Kalaydjiev S, Busch DH, Pfeffer K, Mampaso F, Schlöndorff D, Luckow B.
    J Am Soc Nephrol; 2005 Dec 01; 16(12):3592-601. PubMed ID: 16267157
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 18.